Khozeimeh F,
Ziaei S, Khalesi S, Allameh M, Jahanshahi G. The efficacy of photodynamic
therapy in rat tongue dysplasia. J Clin Exp Dent. 2019;11(7):e587-92.
doi:10.4317/jced.54425
http://dx.doi.org/10.4317/jced.54425
______________________________________________________________________________________________________________________________________
References
|
1. Speight PM. Update on
oral epithelial dysplasia and progression to cancer. Head Neck Pathol. 2007;1:61-6. |
|
|
|
|
|
2. Mehanna HM, Rattay T,
Smith J, McConkey CC. Treatment and follow-up of oral dysplasia - a
systematic review and meta-analysis. Head Neck. 2009;31:1600-9. |
|
|
|
|
|
3. Zhang L, Poh CF, Lam WL,
Epstein JB, Cheng X, Zhang X, et al. Impact of localized treatment in
reducing risk of progression of low-grade oral dysplasia: molecular evidence
of incomplete resection. Oral Oncol. 2001;37:505-12. |
|
|
|
|
|
4. Agostinis P, Berg K,
Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. Photodynamic therapy of
cancer: an update. CA Cancer J Clin. 2011;61:250-81. |
|
|
|
|
|
5.
Dolmans DE, Fukumura D, Jain RK. Photodynamic
therapy for cancer. Nat Rev Cancer. 2003;3:380-7. |
|
|
|
|
|
6. Gold MH, Goldman MP.
5-aminolevulinic acid photodynamic therapy: where we have been and where we
are going. Dermatol
surg. 2004;30:1077-83; discussion 83-4. |
|
|
|
|
|
7.
Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, et al.
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 1997;79:2282-308. |
|
|
|
|
|
8. Castano AP, Demidova TN,
Hamblin MR. Mechanisms in photodynamic therapy: part one-photosensitizers,
photochemistry and cellular localization. Photodiagnosis Photodyn Ther. 2004;1:279-93. |
|
|
|
|
|
9. Kennedy JC, Pottier RH,
Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic
principles and present clinical experience. J Photochem Photobiol B. 1990;6:143-8. |
|
|
|
|
|
10. Yamamoto K, Kitayama W,
Denda A, Morisaki A, Kuniyasu H, Kirita T. Inhibitory effects of selective
cyclooxygenase-2 inhibitors, nimesulide and etodolac, on the development of
squamous cell dysplasias and carcinomas of the tongue in rats initiated with
4-nitroquinoline 1-oxide. Cancer Lett. 2003;199:121-9. |
|
|
|
|
|
11. Tanaka T, Nishikawa A,
Mori Y, Morishita Y, Mori H. Inhibitory effects of non-steroidal
anti-inflammatory drugs, piroxicam and indomethacin on 4-nitroquinoline
1-oxide-induced tongue carcinogenesis in male ACI/N rats. Cancer Lett. 1989;48:177-82. |
|
|
|
|
|
12. Sohrabi M, Kalati FA,
Vatansever S, Abbasi MM, Roshangar L, Khaki AA, et al. Effect of dietary and
topical Celecoxib on expression of bcl-2, bax, c-erb-B2 and Ki67 in
carcinogen-induced tongue carcinoma in rat. Pak J Biol Sci. 2009;12:750-7. |
|
|
|
|
|
13. Gannot G, Buchner A,
Keisari Y. Interaction between the immune system and tongue squamous cell
carcinoma induced by 4-nitroquinoline N-oxide in mice. Oral Oncol. 2004;40:287-97. |
|
|
|
|
|
14. Zaidi SIA, Oleinick NL,
Zaim MT, Mukhtar H. Apoptosis during photodynamic therapy-induced ablation of
rif-1 tumors in c3h mice: electron microscopic, histopathologic and
biochemical evidence. Photochem
Photobiol. 1993;58:771-6. |
|
|
|
|
|
15. Henderson BW, Waldow SM,
Mang TS, Potter WR, Malone PB, Dougherty TJ. Tumor destruction and kinetics
of tumor cell death in two experimental mouse tumors following photodynamic
therapy. Cancer
Res. 1985;45:572-6. |
|
|
|
|
|
16. Fink-Puches R, Soyer H,
Hofer A, Kerl H, Wolf P. Long-term follow-up and histological changes of
superficial nonmelanoma skin cancers treated with topical δ-aminolevulinic acid photodynamic therapy. Arch Dermatol. 1998;134:821-6. |
|